Rating History for Celldex Therapeutics (CLDX) by Wolfe Research
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/23/2026 | Andy Chen | Upgrade | Outperform (Peerperform) |
44.00 (N/A) |
30.90 (32.43) |
4.95% | Details |
 |
|||||||
|
|||||||
